NCT07840274Completed
Effects of Daily Kefir Consumption During Medical Nutrition Therapy on Body Composition and Psychological Well-Being in Women With Obesity
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
This randomized controlled study evaluated the effects of daily kefir consumption as an adjunct to medical nutrition therapy on body composition, biochemical parameters, gastrointestinal symptoms, bowel habits, and psychological well-being in women with obesity. Participants were randomly assigned to receive either 200 mL of plain kefir daily together with individualized medical nutrition therapy or individualized medical nutrition therapy alone for 12 weeks. Assessments were performed at baseline, week 6, and week 12. The primary outcome was change in body weight. Secondary outcomes included changes in body composition, biochemical parameters, gastrointestinal symptoms, bowel habits, and psychological well-being.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 68 (actual)
- First submitted
- 18 Sept 2026
- Start date
- Jun 2024
- Primary completion date
- Sept 2024
- Lead sponsor
- Pınar Göbel
- Diseases
- Obesity
- NCT number
- NCT07840274
What you commit to
- Study type: Interventional
- Participants enrolled: 68
- From Jun 2024 to the primary completion date, Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of chronic diseases.
- Known allergy or intolerance to kefir or dairy products.
Other
- Pregnancy or lactation.
- Current use of antibiotics, probiotic supplements, or prebiotic supplements during the study period.
- Inability to comply with the intervention or follow-up procedures.
Criteria the registry did not label
- nclusion Criteria:
- Female participants aged 25-55 years.
- Body mass index (BMI) ≥30 kg/m².
- Willingness to participate in the study and comply with the intervention protocol.
- Provision of written informed consent.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Healthy Living Center, Karabük Coordinator of this site? Confirm its status | Karabük | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.